Company intelligence / Profile preview

Hello Inside

Ownership: Private
Development stage: Commercial

Overview

Hello Inside offers a commercial digital platform that uses continuous glucose monitoring and AI to provide personalized metabolic insights for women. The service has demonstrated high user engagement and reported an 80% weight-goal success rate within 30 days among users. Ongoing efforts include clinical validation of their engagement model in collaboration with research partners[1][5].

Therapeutic areas: Metabolic DisordersEndocrinologyWomen's Health
Modalities: DeviceNon-pharmacological therapyDigital health intervention
Industry: Digital Health Medical Devices

Partnerships

Mira HealthCitruslabs

Beyond the preview

Go deeper on Hello Inside.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hello Inside.

Explore the full profile